← Back to All Filings

Cencora Insider Plans $1.75M Stock Sale Under 10b5-1 Plan

Low SignificanceDecember 18, 2025 at 10:02:14 AM EST

Cencora, Inc.

$COR144CIK: 0001140859

Subscribe to track COR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Cencora Insider Plans $1.75M Stock Sale Under 10b5-1 Plan

Company: Cencora, Inc. (Ticker not provided in filing) Form: 144 | Filed: 2025/12/18 Significance: Low

Insider: Mauch Robert P. Title: Officer | Relationship: Officer, Director

Transaction: • Type: Proposed Sale • Shares: 5,096 • Price: ~$343.45 • Value: $1,750,221 • Owned After: Not specified

Key Insight: This is a notice of a proposed sale under a pre-established 10b5-1 trading plan, indicating it was scheduled in advance and is likely for personal financial planning rather than a reaction to recent company events.

Market Context: The transaction represents a negligible fraction (0.0025%) of Cencora's $70.17B market cap, suggesting minimal market impact.

Comprehensive Analysis

SEC Filing Analysis: Cencora, Inc.

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An Officer and Director of Cencora, Inc. has filed a notice to sell $1.75 million worth of common stock under a pre-arranged 10b5-1 trading plan.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and is not expected to have a meaningful impact on the stock price.

Company Information

FieldValue
CompanyCencora, Inc.
Ticker SymbolNot specified in filing
CIK0001140859
IndustryWholesale-Drugs Proprietaries & Druggists' Sundries

Insider Information

FieldValue
NameMauch Robert P.
CIK0001633897
Title/PositionOfficer
RelationshipOfficer, Director

Transaction Details

FieldValue
Form Type144
Transaction Date2025/12/18 (Approximate Sale Date)
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved5,096
Price Per Share~$343.45 (Calculated)
Total Value$1,750,221.20
Shares Owned AfterNot specified
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,750,221.20
% of Market Cap0.0025%
Shares Transacted5,096
% of Shares Outstanding0.0026%
Post-Transaction OwnershipNot specified
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Cencora is a mega-cap company with a market capitalization of $70.17 billion. A transaction of $1.75 million is financially insignificant for a company of this scale.
  • Transaction Significance: The sale represents a negligible percentage of both the market cap (0.0025%) and shares outstanding (0.0026%), falling far below any threshold for materiality. This is a routine transaction for an executive at a large corporation.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is extremely small relative to the company's size and daily trading volume. More importantly, it is being conducted under a 10b5-1 plan adopted on May 23, 2025, which means the decision to sell was made months in advance and is not based on current, non-public information.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 5,096 shares will be easily absorbed by the market without noticeable impact.
  • Sentiment Indicator: Neutral. Pre-planned sales by executives are common for portfolio diversification and liquidity and do not typically influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: This sale is part of a pre-disclosed 10b5-1 trading plan. The filing also shows a consistent pattern of similar-sized sales by the same insider over the past three months, reinforcing the routine nature of these transactions.
Topics:#SECFiling#InsiderTrading#Cencora#Form144#InsiderSell#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.